|
|
42
|
3633AG
|
METOCLOPRAMIDE 5MG/ML IV/IM INJ (MO
|
10X2ML
|
B
|
0.65
|
5MG/ML IV/IM
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
3633AV
|
METOCLOPRAMIDE 5MG/ML IV/IM INJ (FSB) (B)
|
10X2ML
|
B
|
0.4322
|
5MG/ML IV/IM
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
40
|
3653AJ
|
RYNASE AQ 64MCG NASAL SP (CAR/COL) BUDESONIDE
|
240 DOSES
|
A
|
15.98
|
64MCG
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
3653AJ
|
RYNASE AQ 64MCG NASAL SP (CAR) BUDESONID
|
240 DOSES
|
A
|
16.2556
|
64MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
3653AJ
|
RYNASE AQ 64MCG NASAL SP (CAR) BUDESONID
|
240 DOSES
|
A
|
16.26
|
64MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
3653BJ
|
AVAMYS 27.5MCG NASAL SP (GSK/COL) FLUTICASONE
|
120 DOSES
|
C
|
25.14
|
27.5MCG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
3653BJ
|
AVAMYS 27.5MCG NASAL SP (GSK) FLUTICASON (C)
|
120 DOSES
|
C
|
26.6668
|
27.5MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
3653BJ
|
AVAMYS 27.5MCG NASAL SP (GSK) FLUTICASONE
|
120 DOSES
|
C
|
29.33
|
27.5MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
3653BK
|
RYNASE AQ 32MCG NASAL SP (CAR/COL) BUDESONIDE
|
120 DOSES
|
C
|
8.15
|
32MCG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
3653BK
|
RYNASE AQ 32MCG NASAL SP (CAR) BUDESONID (C)
|
120 DOSES
|
C
|
8.4268
|
32MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
3653C
|
NASASONE MF 50MCG NASAL SP (CAR/COL) MOMETASO
|
140 DOSES
|
C
|
9.65
|
50MCG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
3653C
|
NASASONE MF 50MCG NASAL SP (CAR) MOMETAS
|
140 DOSES
|
A
|
9.2423
|
50MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
3653C
|
NASASONE MF 50MCG NASAL SP (CAR) MOMETAS
|
140 DOSES
|
C
|
9.24
|
50MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
3653CD
|
BUDESONIDE 64MCG NASAL SP (CIR)
|
200 DOSES
|
A
|
14.43
|
64MCG
|
1
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
3653CE
|
FLUTICASONE 27.5MCG NASAL SP (CIR/AHI)
|
200 DOSES
|
A
|
14.68
|
27.5MCG
|
1
|
2022-04-01
|
2022-09-30
|
|
|
|
6
|
|
|
41
|
3653CE
|
FLUTICASONE 27.5MCG NASAL SP (CIR)
|
200 DOSES
|
A
|
14.1353
|
27.5MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
3653CF
|
FLUTICASONE 50MCG NASAL SP (CIR/AHI)
|
200 DOSES
|
A
|
14.08
|
50MCG
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|
|
|
41
|
3653CF
|
FLUTICASONE 50MCG NASAL SP (CIR)
|
200 DOSES
|
A
|
15.277
|
50MCG
|
1
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
40
|
3653CK
|
MOMETASONE 50MCG NASAL SP (BCH/COL)
|
140 DOSES
|
A
|
9.08
|
50MCG
|
1
|
2022-04-01
|
2024-03-31
|
|
|
Add to Contract as Cat A
|
6
|
|
|
40
|
3653CS
|
FLUTICASONE 27.5MCG NASAL SP (ARP/AHI)
|
120 DOSES
|
A
|
12.99
|
27.5MCG
|
1
|
2022-04-01
|
2024-03-31
|
|
|
|
6
|